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Abstract—For people with Type 1 diabetes (T1D), forecasting
of blood glucose (BG) can be used to effectively avoid hyper-
glycemia, hypoglycemia and associated complications. The latest
continuous glucose monitoring (CGM) technology allows people
to observe glucose in real-time. However, an accurate glucose
forecast remains a challenge. In this work, we introduce GluNet, a
framework that leverages on a personalized deep neural network
to predict the probabilistic distribution of short-term (30-60
minutes) future CGM measurements for subjects with T1D based
on their historical data including glucose measurements, meal
information, insulin doses, and other factors. It adopts the latest
deep learning techniques consisting of four components: data
pre-processing, label transform/recover, multi-layers of dilated
convolution neural network (CNN), and post-processing. The
method is evaluated in-silico for both adult and adolescent
subjects. The results show significant improvements over existing
methods in the literature through a comprehensive comparison
in terms of root mean square error (RMSE) (8.88±0.77 mg/dL)
with short time lag (0.83±0.40 minutes) for prediction horizons
(PH) = 30 mins (minutes), and RMSE (19.90±3.17 mg/dL) with
time lag (16.43± 4.07 mins) for PH = 60 mins for virtual adult
subjects. In addition, GluNet is also tested on two clinical data
sets. Results show that it achieves an RMSE (19.28±2.76 mg/dL)
with time lag (8.03±4.07 mins) for PH = 30 mins and an RMSE
(31.83±3.49 mg/dL) with time lag (17.78±8.00 mins) for PH = 60
mins. These are the best reported results for glucose forecasting
when compared with other methods including the neural network
for predicting glucose (NNPG), the support vector regression
(SVR), the latent variable with exogenous input (LVX), and the
auto regression with exogenous input (ARX) algorithm.
Index Terms—Deep learning, dilated convolutions, glucose
forecasting, continuous glucose monitoring (CGM), diabetes.
I. INTRODUCTION
Diabetes is a chronic disease that affects about 415 million
people around the world [1]. There are two main types of dia-
betes: Type-1 diabetes (T1D) and Type-2 diabetes (T2D). For
people with T1D, exogenous insulin administration is required
to manage BG levels in the target range (70-180mg/dl) to avoid
hypoglycemia (< 70mg/dl) or hyperglycemia (> 180mg/dl).
The recent developments in CGM technology [2] provide real-
time monitoring of the current glucose, so people can observe
their glucose concentration trend visually on devices. It has
been proven that CGM technology helps T1D subjects to have
a better glycemic control [3], [4] by alerting them when hypo-
or hyperglycemia events occur [5]–[7].
In recent years many algorithms have been proposed for
glucose forecasting [8], such as polynomial models (autore-
gressive (AR), autoregressive exogenous (ARX), autoregres-
sive moving-average (ARMA)) [9], machine learning models
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[10] and latent-variable-based statistical models [11]. Oviedo
et al. [8] reviewed the topic comprehensively. In addition,
machine learning (ML) techniques were extensively exploited,
including support vector regression (SVR) [12], random forest
(RF) [13] and grammatical evolution [14]. Deep learning (DL)
is a promising ML technique which is still relatively new in
this field. DL has potential because it can capture the complex
dynamics of systems, particularly when it is difficult to derive
the mathematical expressions of the system. DL has improved
the state-of-the-art performance significantly in computer vi-
sion (CV) and bio-engineering applications [15]. There are
a few works to date using DL for glucose forecasting. For
instance, in [10], [16] traditional dense neural networks were
used but without exploiting the advantages of deep layers.
In [17], two latent layer neural networks were adopted for
hypo/hyperglycemia prediction. However, this work lacks a
comprehensive comparison with other algorithms.
In this paper we introduce GluNet, a framework that lever-
ages deep neural networks (DNN) for forecasting accurate
short-time CGM measurements (PH = 30 minutes and 60
minutes) using life-style data. These data include historical BG
data from CGM, meal intake, insulin dosage. Other data from
wearable technology or physiological glucose-insulin regula-
tory models are optional. GluNet consists of several compo-
nents, including data preprocessing, label transform/recover,
multi-layers of dilated convolution neural network (CNN),
gated activations, residual and skip connections. The original
idea comes from PixelCNN [18] and Wavenet [19], which
are DL models used in CV and acoustic signal processing.
Dilated CNNs are good at processing multi-dimensional long
signals with a wider receptive field, and gated activation units
capture the non-linearity of the probabilistic relations among
several inputs. We modify PixelCNN/Wavenet accordingly to
make it appropriate for glucose forecasting, and the DNN
becomes a predictive model with fast implementation instead
of a generative model. GluNet offers a personalized glucose
forecast, and the model can evolve when new personal data
are collected. We have evaluated GluNet on 10 simulated
virtual T1D adult and adolescent subjects, respectively, gen-
erated from the UVA/Padova T1D simulator [20], as well
as two clinical dataset including 10 T1D subjects from the
ABC4D project using DexcomTM CGM sensors [21], and
6 T1D subjects from Ohio Dataset [22]. The results show
that the proposed framework achieves state-of-the-art glucose
forecasting in terms of accuracy and time lag on both in silico
and the clinical dataset.
2Fig. 1: An illustration of clinical CGM glucose time series and CGM measurements forecasting. x-axis stands for glycemic
samples; y-left-axis represents the blood glucose level (in mg/dl). Green dots are glucose measurements sampled every 5
minutes by CGM in real-time. Purple dots are the insulin dosage (in units) shown on y-right-axis. Yellow dots denote the food
carbohydrate (in gram) shown on the y-right-axis. The blue zigzag line represents the scale of one day length starting from the
lowest point (0:00) to the highest point (24:00). The pink area means the hypoglycemia field (< 70 mg/dl) and hyperglycemia
field (> 180 mg/dl). Dash lines at the right end of the green dots demonstrate several future forecasting glucose curves.
II. GLUNET
A. Problem Formulation
If a d-dimensional xT = [x1, · · · ,xT ]ᵀ ∈ RT×d is the con-
catenation of historical data and features, where xt = [mt,nt]
consists of d1-dimensional historical data and d2-dimensional
features,
mt = [mt(1),mt(2), · · ·mt(d1)] ∈ Rd1 ,
nt = [nt(1), nt(2), · · ·nt(d2)] ∈ Rd2 ,
(1)
where d2-dimensional features nt are computed from mt, d =
d1+d2, and mt(1) , Gt is the CGM data at time t. Then the
joint probability of the forecasting glucose, p(G′), is factorised
as a product of conditional probabilities as follows
p (G′) =
T−w∏
t=1
p
(
G′t+w|G1, · · · , Gt
)
, (2)
where w represents the number of glycemic samples in terms
of the PH, and the forecasting glucose sample G′t+w is
therefore conditioned on the glucose samples at all previous
timesteps. Specifically, the CGM measures the glucose every
5 minutes. If we forecast the glucose of next 30 minutes
indicating PH= 30, then we set w = 30/5 = 6 samples. Note
that 30 mins PH has been widely used in the literature [8]
and applied in the Medtronic MiniMed 640G insulin pump.
Because Pi (plasma insulin estimation) and Ra (glucose rate
of appearance) relate to glucose dynamics G in addition to
meal M and insulin I, for instance, we may set d1 = 3, d2 = 2
where mt , [Gt,Mt, It] and nt , [Pit, Rat], where
{Pit, Rat} can be calculated from {Gt,Mt, It} and other
information of subjects such as body weight [23]. The factors
in consideration in x can be changed accordingly, depending
on the data we can collect.
In both training and inference, multi-dimensional health data
are sent to the network as batches determined by a sliding
window. GluNet uses a stack of dilated convolutional layers
to model the conditional probability distribution. We set the
outputs of GluNet as a classification over the next forecasting
value G′t+w targeting at the value Gt+w with a softmax layer.
It is to maximize the log-likelihood of the data with regard to
the parameters
max log
{
T−w∏
t=1
p (Gt+w|x1, · · · ,xt)
}
. (3)
After the training phase, the forecasting glucose G′t+w’s distri-
bution is computed for inference. We tune the hyperparameters
on a validation set to avoid overfitting or underfitting carefully.
B. The Architecture of GluNet
GluNet has four components. They are preprocessing, label
transforms and recover, multi-layers of dilated convolutions,
postprocessing. In the preprocessing, we clean the data mt,
compute useful nt, and prepare them for the DNN use. The
label transform component converts the glucose G to the
difference 4G between current glucose Gt and PH glucose
Gt+w. While in the inference, forecasting glucose is recovered
from 4G. The main ingredients of GluNet are multi-layers
of dilated convolutions and gated activations. A stack of
dilated convolutional layers are placed. Both residual and
parameterised skip connections are applied throughout the
network aiming at speeding up the convergence. In addition,
we calculate the dilated CNN in a faster manner by eliminating
redundant operations. Fig 2 shows the architecture of GluNet.
C. Preprocessing
A preprocessing component is designed to clean the input
data. There are several steps, P1: ruling out outliers, P2,
P3: interpolation/extrapolation, P4: computing features, P5:
alignment. The specific approaches of preprocessing depend
on the specific dataset we have. 1) Rule out outliers: The
outliers come from the error in CGM measurements, the
transmission of CMG data, or incorrect behaviours when
people record the data (meal, insulin). These outlier data points
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Fig. 2: The architecture of GluNet. It consists of four parts: preprocessing, DNN, postprocessing and label transform and
recover. The input data are CGM measurements time series G, insulin I and meal M . More input factors are optional. In
the preprocessing, P1: rule out outliers in G, I,M ; P2: interpolation of G when the missing data gap is not large; P3: fill
or estimate the missing data in I,M ; P4: calculate other factors as input to the DNN, for instance plasma insulin estimation
Pi and glucose rate of appearance Ra; P5: align all factors with the same timeline and use them as input to the DNN. The
aligned BG time series Gt is also sent to the label transform, and quantized 4G′t is used as the category target in training.
are supposed to be ruled out. In GluNet we set thresholds
in the highest, lowest, and largest differential of the CGM
measurements. Sometimes certain meal or insulin values in M
or I are too large or too small, which implies that they might
be mistakes. We identify these values by threshold method
and correct them appropriately. 2) Interpolation/extrapolation:
Spline interpolation or extrapolation technique are used when
the missing CGM data are less than one hour (12 samples).
Spline interpolation is implemented because it is more ac-
curate, and simpler than some other methods [24]. If the
missing CMG data are longer than 1 hour, we consider it as a
separate dataset in training. In the inference, extrapolation is
adopted because future samples cannot be used in forecasting.
3) Considering other factors (optional): Given {I,M}, we
utilize the insulin absorption model and the glucose absorption
model proposed in [23] to compute Ra and Pi based on
the estimation technique proposed by Hovorka in [25], where
Ra denotes the glucose rate of appearance, Pi represents the
plasma insulin estimation. More factors can be incorporated
optionally. 4) Alignment: All data are aligned to G to generate
multi-channel data that have the same length of G.
D. Label Transform and Recover
Aiming at increasing the predictive accuracy, a label trans-
form component is placed before DNN. Rather than directly
forecasting Gt+w we forecast the difference between Gt+w
and Gt denoted as4Gt = Gt+w−Gt in the training. An index
of quantized 4Gt, denoted as 4G∗t , is used as the output
label. Without loss of generality the dimension of the output
labels is set as 256. It represents that 4Gt varies from −12.7
to 12.8 mg/dl, where each label denotes a quantized index
4G∗t with a quantizing interval of 0.1 mg/dl. Specifically, the
label index 4G∗t can be calculated as
4G∗t =
 1 for 4Gt < −12.75R(10(4Gt + 12.8)) for −12.75 < 4Gt < 12.85
256 for 4Gt > 12.85
(4)
where R denotes a round quantization operator that converts
a decimal to an integer. In this way the predictive task is
converted to a classification task: given previous data, the
model computes the forecasting probability distribution of
4Gt. GluNet forecasts the future glucose as the inference of
the DNN by recovering BG values from label indexes. It is a
reverse process of the previous label transform. Firstly 4G′t
is computed using a reverse equation of (4) from inference
value 4G′t∗. Then the forecast G′t+w can be derived from
G′t+w = 4G′t +Gt where Gt is the current glucose.
E. Dilated CNN
CNN is a feed-forward artificial neural network, and the
calculation that performs in each layer is convolution. In
GluNet we use the multi-layer convolutional NN to build
the model. A visualization of a stack of causal convolutional
layers is shown in Fig. 3 (I), where the forecast at timestep
t depends on previous inputs. In PixelCNN, the convolution
operator is equivalent to implementing a mask on image pixels
by calculating an elementwise multiplication of the mask with
the convolution kernel. For time series one can implement it
by shifting output of normal convolutions. Because the model
has no recurrent connections, the training process is faster than
neural networks with recurrent structure. It is important for
training long time series. One problem of the casual CNN is
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Fig. 3: Visualization of a stack of causal convolutional layers and dilated convolutional layers, where each has 3 hidden layers,
orange and green notes represent input and output, respectively. (I) A stack of causal convolutional layers with a receptive
field of 5. (II) A stack of dilated convolutional layers with a receptive field of 16.
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Fig. 4: The diagram of fast dilations. The generation model
is initialized with weights from the previous network. After
initialization we repeat the pop and push phase iteratively.
that it has a narrow receptive field. Its number of receptive
field is similar to the number of layers. To solve it we utilize
dilated convolutions to increase the receptive field without
significantly increasing computational cost. The key idea of
dilated CNN is that it skips the input values in each layer with
certain steps, which allows the network to operate on a larger
scale that increases the receptive field by orders of the number
of layers. As shown in Fig. 3 (II), the dilation is {1, 2, 4, 8},
while in casual CNN the dilation remains {1, 1, 1, 1}.
Moreover, to accelerate the computation, we implement
dilated CNN in an efficient manner. Popping and pushing
recurrent states in the cache are applied to eliminate redundant
convolution operations [26]. It reduces computations from
O(2L) to O(L), where L is the number of layers. Fig. 4
illustrates how it works when dilation is doubled in each layer.
Specifically, in the pop phase the convolution queue pops the
recurrent state and feeds it to the corresponding state. Then
the new hidden states and the output are calculated. While in
the push phase, the algorithm pushes the new hidden state into
the convolution queue of the above layer. After that, a softmax
operator is leveraged to impose the non-linearity using a µ-
law transformation [19] to produces a better reconstruction
f(xt)− sign(xt) 1+µ|xt|)ln(1+µ) , where |xt| < 1 and µ = 255.
F. Postprocessing
The postprocessing consists of skip connections and a series
of operations. Please refer to Appendix for details. Postpro-
cessing and dilated CNN form the DNN part of GluNet.
III. RESULTS
A. Dataset and Model
1) In silico Data: The adult and adolescent virtual subjects
from the UVA/Padova T1D simulator were employed. We
generated 180 days data with 3 meals per day for the 10
virtual adult and 10 virtual adolescent subjects. The generated
glucose dataset is a time series with 288 points per day. The
intra-day variability is applied in meal size [27] with variability
10%, meal time with STD = 60 mins and meal amount mis-
estimation [-0.3,0.2]. Furthermore, 30 minutes of exercise with
time variability 10% is considered for 2 days per week, and its
time varies in the morning, afternoon or evening. Insulin data
has several entries per day. The time of insulin entries can be
the same as a meal time, or at different time. These settings
are variant enough for simulating subjects’ daily data under
different conditions. Each dataset was randomly divided into
two parts: training set and testing set, where each accounted
for 50% of the dataset. In the training set, 90%, 10% partition
is set as the training/validation strategy.
2) Clinical Data: There are two clinical datasets. The first
one was obtained from our ABC4D project [21]. T1D diabetic
subjects participated and were monitored for 6 consecutive
months with Dexcom CGM devices (San Diego, CA). Infor-
mation on meals, insulin dosages were recorded by the patients
themselves through a dedicated App. Similar to the simulated
data, each clinical dataset was randomly divided into training
set and testing set, where each accounted for around 90 days
(50%) of the dataset. The second dataset was provided by
the Blood Glucose Level Prediction Challenge, namely the
OhioT1DM dataset [22]. During eight weeks’ period, six T1D
subjects wore CGM devices and insulin pumps and reported
their data regularly. A smart-phone app and a fitness band were
used to collect daily events. OhioT1DM dataset is different
from other datasets, because its training set and the testing set
have been separated by the Challenge, for around 40 days for
training and 10 days for testing, respectively.
3) Model Structure and Comparison: In the model frame-
work we use a CNN with 5 layers. For the first three layers,
the hidden units are set to 32, while the top two layer has
64 neurons. We use the sliding window of size 16 time-steps
to derive one forecast sample for the future glucose with a
many-to-one structure. The inputs are glucose, meal, insulin
and time stamps. Only these information are used because
5TABLE I: Prediction performance for the considered prediction methods evaluated on the 10-adult virtual subjects.
PH Methods RMSE (mg/dL) MARD (%) Time lag (mins) PH Methods RMSE (mg/dL) MARD (%) Time lag (mins)
30
m
in
ut
es GluNet 8.88±0.77 5.32±0.66 0.83±0.40
60
m
in
ut
es GluNet 19.90±3.17 10.55±1.40 16.43±4.07
NNPG 13.55±1.30‡ 7.55±1.10‡ 10.12±1.67† NNPG 24.69±3.19‡ 13.39±2.10‡ 30.92±5.11‡
SVR 14.65±1.78‡ 7.58±1.05‡ 11.55±2.00‡ SVR 25.34±3.71‡ 13.16±1.89‡ 32.62±4.35‡
LVX 12.25±1.40‡ 7.29±1.02‡ 6.54±2.08‡ LVX 22.41±2.89‡ 14.06±2.76‡ 35.79±2.79‡
ARX 13.26±1.25‡ 7.88±1.24‡ 9.63±1.64‡ ARX 25.73±3.41‡ 14.71±2.68‡ 40.18±2.71‡
∗p ≤ 0.05 †p ≤ 0.01 ‡p ≤ 0.005
TABLE II: Prediction performance for the considered prediction methods evaluated on the 10-adolescent virtual subjects.
PH Methods RMSE (mg/dL) MARD (%) Time lag (mins) PH Methods RMSE (mg/dL) MARD (%) Time lag (mins)
30
m
in
ut
es GluNet 10.73±1.66 5.77±0.88 1.44±0.72
60
m
in
ut
es GluNet 22.65±4.71 11.23±1.96 12.81±2.86
NNPG 16.72±3.18‡ 9.25±2.60‡ 9.86±1.99† NNPG 32.58±7.43‡ 16.55±2.83‡ 31.69±4.17‡
SVR 19.72±4.86‡ 8.88±1.48‡ 12.20±2.15‡ SVR 34.62±8.54‡ 16.29±2.49‡ 33.80±4.45‡
LVX 14.99±3.20‡ 8.07±1.24‡ 7.36±1.94‡ LVX 31.08±7.78‡ 15.31±2.41‡ 26.48±3.66‡
ARX 15.24±2.44‡ 8.21±1.37‡ 8.16±1.31‡ ARX 33.21±6.84‡ 18.57±3.00‡ 38.79±2.97‡
∗p ≤ 0.05 †p ≤ 0.01 ‡p ≤ 0.005
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Fig. 5: Virtual adult 2.
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Fig. 6: Virtual adolescent 2
Fig. 7: One day period forecasting results. The solid black line, solid red line, dash-dotted magenta line, dashed cyan line, and
dotted green line indicate the simulated glucose measurements, the forecasting results of the GluNet, NNPG, LVX, SVR, and
the ARX method, respectively.
we want to have a fair comparison that all methods share
the same input data. We compare our results with the neural
network for predicting glucose algorithm (NNPG) in [28], the
latent variable with exogenous input (LVX) statistical method
proposed in [29], the auto regression with exogenous input
(ARX) method [30], and the support vector regression (SVR)
[12] method. 30 and 60 minutes PH are considered.
B. Evaluation metrics
The efficiency and accuracy of our proposed method will be
demonstrated with the root mean square error (RMSE) results
in mg/dL and the mean absolute relative difference (MARD)
in %, calculated by
RMSE =
√√√√ 1
N
N∑
k=1
(yk − yˆk)2, MARD = 1
N
N∑
k=1
|yk − yˆk|
yk
,
(5)
where y denotes the CGM measurement and yˆ denotes the
forecasting results, N is the total data numbers. Also a
prediction time lag (or called prediction time delay [28]) is
computed to measure the time-shift between the actual and
predicted signal which gives the highest cross correlation
coefficient between them:
τdelay = argmax
k
(yˆk(k|k − PH) ? y(k)). (6)
The prediction time lag provides an accurate estimate of the
delay (or offset) in predictions [31]. We use these three criteria
because they are widely used in evaluating the glucose forecast
in the literature.
C. In Silico Results
Table I demonstrates the forecasting performance of the
proposed GluNet, NNPG, LVX, SVR, and ARX algorithm,
in terms of the corresponding mean values and standard devi-
ations (STD) of RMSE (mg/dL), MARD (%) for the 10 adults
from the UVA/Padova T1D simulator. Table II demonstrates
the forecasting performance for the 10 adolescents from the
UVA/Padova T1D simulator, with a same setting to Table I.
From Table I, we can see that GluNet has the smallest
RMSE and MARD. The mean value of RMSE are much
improved (GluNet 8.88 ± 0.77 v.s. others best 12.25 ± 1.40
for PH = 30 mins). This verifies GluNet’s superiority that it
performs well for virtual adult subjects. Also the shortest Time
lag shows that the algorithm can discover the glucose change
6TABLE III: Forecasting performance for the methods evaluated on the 10 ABC4D adult subjects.
PH Methods RMSE (mg/dL) MARD (%) Time lag (mins) PH Methods RMSE (mg/dL) MARD (%) Time lag (mins)
30
m
in
ut
es GluNet 19.19±2.74 10.41±1.53 11.34±3.09
60
m
in
ut
es GluNet 31.78±4.94 19.28±3.85 30.28±6.56
NNPG 20.42±2.76∗ 11.91±2.32∗ 13.88±3.11† NNPG 33.13±5.28† 20.59±4.97∗ 35.08±4.49∗
SVR 24.96±4.00‡ 13.04±2.03† 14.58±2.93‡ SVR 36.25±5.95‡ 21.12±3.77‡ 32.36±5.09‡
LVX 21.52±3.09‡ 12.45±1.95∗ 15.50±3.31‡ LVX 37.34±6.40‡ 20.06±3.40 41.44±5.27‡
ARX 21.24±3.01‡ 12.15±2.22∗ 17.80±2.35‡ ARX 36.17±5.65‡ 19.85±3.25 46.29±2.57‡
∗p ≤ 0.05 †p ≤ 0.01 ‡p ≤ 0.005
TABLE IV: Forecasting performance for the considered prediction methods evaluated on the 6 OhioT1DM subjects.
PH Methods RMSE (mg/dL) MARD (%) Time lag (mins) PH Methods RMSE (mg/dL) MARD (%) Time lag (mins)
30
m
in
ut
es GluNet 19.28±2.76 8.73±1.78 8.03±4.07
60
m
in
ut
es GluNet 31.83±3.49 16.11±4.49 17.78±8.00
NNPG 22.93±2.95‡ 10.76±2.84‡ 16.42±4.21‡ NNPG 35.77±3.50† 17.75±4.78∗ 30.72±15.28‡
SVR 21.75±1.86∗ 9.23±2.15 9.86±4.46 SVR 34.31±2.85∗ 17.86±4.63∗ 20.89±11.40∗
LVX 21.70±3.28‡ 9.50±2.13∗ 11.75±5.64∗ LVX 38.95±12.76‡ 17.69±3.17 27.06±12.23‡
ARX 21.54±2.42‡ 9.17±2.06 11.06±6.21∗ ARX 39.53±14.47‡ 17.58±2.98 35.53±9.38‡
∗p ≤ 0.05 †p ≤ 0.01 ‡p ≤ 0.005
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Fig. 8: 1.5 day period forecasting results for adult 2.
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Fig. 9: 1.5 day period prediction results for subject 570.
Fig. 10: 1.5 day period forecasting results for clinical dataset. The solid black line, solid red line, dash-dotted magenta line,
dashed cyan line, and dotted green line indicate the simulated glucose measurements, the forecasting results of the GluNet,
NNPG, LVX, SVR, and the ARX method, respectively.
promptly. Meanwhile, the GluNet method achieves the best
performance in the case of PH = 60 mins, in terms of RMSE,
MARD and Time lag. Fig. 5 demonstrates that GluNet has less
oscillation, especially in the rising period after meal intake.
In the rising and the dropping stage, forecasting results of
GluNet can follow the CGM samples more closely than those
of other methods. It explains why GluNet has a small time
lag. If we observe the curves, most proportional curves of real
and GluNet curves match each other. The overall time lag is
computed from the mean of time when it has the highest cross-
correlation over a period of time (e.g. 3 days). If a larger time-
shift is made, despite of reducing the time lag near starting
points of the rising or dropping stage occasionally, the cross-
correlation of the real and GluNet curves will decrease. That is
why the computed time lag is within 1 mins for 30 mins PH.
Small time lag improves the hypo-/hyper-glycaemia forecast-
ing performance. Moreover, results for the virtual adolescent
group are consist with that for the virtual adults. Smallest mean
RMSE, MARD, and Time lag values are achieved, despite of
the fact that the adolescent glucose level normally is more
difficult to model, as shown in Fig. 6.
D. Clinical Results
Though In silico results of GluNet are good, it is important
that all methods are tested using clinical datasets in practice.
As mentioned, two clinical datasets are examined in this
section carefully.
1) ABC4D Datasets: For the 10 adult subjects from the
ABC4D project and considering 30 and 60 minutes prediction
horizon, Table III demonstrates the forecasting performance
in RMSE, MARD for three-month test data, corresponding
to GluNet, NNPG, LVX, SVR, and the ARX algorithm.
Fig. 8 shows 1.5 day period glucose measurements (in solid
black line) and the forecasting results of different methods
for the subject 2. The obtained results for clinic data are
consistent with that for the in silico data, smaller RMSE and
MARD values are achieved for all the subjects and all period
time (note that the gap between measurements and curves of
all methods near meal time are because of the PH offset).
GluNet provides steady forecasting and prompt detection of
the glucose change. However, generally most values are much
worse than the performances for in silico data. It is because
for clinical data, the data has lots of long missing periods, and
the real glucose measurement is more complicated affected by
factors besides meal, insulin and time.
72) OhioT1DM Datasets: Table IV presents the 30-minute
and 60-minute forecasting performance for six subjects from
OhioT1DM datasets in RMSE, MARD, time lag, correspond-
ing to our proposed GluNet, the NNPG, LVX, ARX and
the SVR algorithm. The result is leading in the challenge.
Fig. 9 shows 1.5 day period glucose measurements (in solid
black line) and the prediction results for the subject 570
corresponding to our proposed GluNet method (in solid red
line). As comparison, the results of the NNPG (in solid yellow
line), LVX (in dash-dotted magenta line), SVR (in dashed cyan
line), and ARX method (in dotted green line) are showed.
It is noted that GluNet still has the best RMSE and MARD
performance for the OhioT1DM subjects in Table IV. GluNet
largely reduces the overall forecasting error and outperforms
other methods. Though GluNet performs well, the improve-
ments are not as large as in the last dataset. The reason might
be the short length of training set. In ABC4D dataset, 90 days
data are used in the training, while in OhioT1DM dataset only
40 days data are available for training. Longer training data
usually offers some improvements empirically, in particular
when we don’t have much data at hand. In Fig. 9, we can see
that the prediction curve by GluNet is sensitive to the change
of the glucose levels and obtains small time lags, especially
at the turning points of the uptrend and downtrend. Therefore,
the results are compatible with that for the ABC4D dataset.
Moreover, in type 1 diabetes management the inter- and
intra-patient variability are so large that it is difficult to use
a generalized model for accurate prediction if no data is
available from a new subject. However, in some real clinical
scenarios we only have limited historical datasets from several
recorded subjects and little information of a new subject. To
investigate this problem, we evaluated a generalized GluNet
model on new subjects. Particularly, we trained the model
on data corresponding to five subjects of ABC4D datasets.
Then directly tested it on the rest of subjects one by one. The
result turns out that the mean RMSE of generalized model
is 24.93 mg/dl while the personalized model achieves 20.59
mg/dl, when PH = 30 mins. In addition, if limited new data
is available, transfer learning can be used to upgrade the
generalized GluNet model to a personalized model, like the
work [15] and our work [32]. Thus, GluNet can provide useful
prediction to new users without much data, and accuracy
can be improved as new individual data becomes available.
Integrating with cloud, GPUs and mobiles, it provides us with
a convenient pattern to train and update models in practice.
IV. DISCUSSION
A. Advantages and limitations of GluNet
From the results, we can see that GluNet has several advan-
tages. Firstly, it has a higher forecasting accuracy compared
to other existing algorithms (also see the comparison details
in the next subsection). Secondly, it is simple to implement,
without tedious parameter tuning. Thirdly, it provides richer
information of the future glucose level by means of a prob-
abilistic distribution rather than a single value forecasting.
Most importantly, GluNet has the shortest time lag and can
capture the trend promptly. Here, we implement the proposed
Fig. 11: The display for high and low bounds with the corresponding PH.
algorithm in an Android system on smart phones using Ten-
sorLite. The app offers the glucose forecasting as shown in
Figure 11, as well as its lower and higher bounds with 95%
probability according to the probabilistic distribution. It uses
around 50 MB RAM when sleeping and 100 MB RAM to
make the forecasting. The forecasting only takes around 6 ms
in the model inference, which is much faster than running it
in Python on a laptop.
One potential limitation of GluNet is that the algorithm
heavily relies on the training data quality. In simulation, the
data has longer length and has less variability. Thus when we
have 6 months high quality data as in the simulation, the fore-
casting accuracy and time lag can be very good. However, if
long data missing period exists, such as in the ABC4D dataset,
or the training data is less than two months (in OhioT1DM)
with high variability, the performance is significantly affected.
In future work, the physiological model could be considered
in the DNN model to improve the forecasting performance
under these cases.
B. Comparison with other existing algorithms
We compare GluNet with existing algorithms to show its
effectiveness, including NNPG, SVR, LVX, and ARX. Other
algorithms published in literature have also been considered.
For datasets generated from the simulator, our proposed
method is better than [33] (RMSE = 18.8), [34] (RMSE =
13.7). For real data, GluNet’s RMSE 19.2 is better than 23.4
in [35], and 21.8 in [36]. GluNet’s time lag 11.3 mins is much
better than 20.4 mins in [36] for 30 mins PH. However, due
to the unavailability of the original codes and other paper’s
RMSE, it is not easy to have a fair comparison. We do however
try to compare our results with works that have been recently
published in the following section.
In [37] the algorithm was compared to ARMA, SVR and
doctors on clinical data in terms of RMSE with PH=30 mins.
Because we do not have their clinical data, comparing the
RMSE directly is not fair. Instead we found that their proposed
algorithm is 0.1 better than SVR in terms of RMSE. While
GluNet gains 5.7 better than SVR on our clinical data, which
implies its advantage. The GluNet’s RMSE result of 8.88 for
8virtual adults is also better than the RMSE of 9.40 achieved
in [10]. GluNet’s result was run on 90 training dates and
90 testing dates, which is more convincing than 11 dates
in training and 3 dates in testing from which the result was
obtained in [10]. To summarise, GluNet achieves the state-of-
the-art forecasting accuracy with the shortest time lag when
compared with published methods.
C. Parameter Tuning and Training
For control-theory based algorithms, usually many parame-
ters need to be tuned manually. The forecasting accuracy can
be influenced significantly if non-ideal parameters are adopted.
In GluNet, several hyper-parameters are set before the training,
and these values are fixed for all subjects, such as sliding
window size, learning rate followed by the network size. In
fact, default learning rate is applied in GluNet. While values of
most other parameters are automatically derived via training.
At the end of the training, the validation loss is quite close to
the training loss, and both loss values are converging. It implies
that our model capacity is appropriate and the it shows good
generalization of the model. Early stopping technique is used
and it prevents the overfitting before running too many epochs.
Unlike other glucose forecasting algorithms, GluNet offers a
probabilistic distribution of the forecasting glucose over the
next PH period. Thus it provides richer information for the
users regarding the future glucose trend.
D. Computational Cost
Method Inference (s) Training (s) Structure Overview
GluNet 0.79 878.11/13.26(GPU) 14592 params, 5 layers
NNPG 0.19 407.19 2196 params, 3 layers
SVR 0.54 127.25 RBF Kernel
LVX 0.05 1.73 3 PLS LVs, CCA [38]
ARX 0.14 4.90 3 order
TABLE V: Computational time of the methods.
To compare computational cost of GluNet with other meth-
ods, we run the models on the subjects from the OhioT1DM
datasets using the same hardware. Table V presents the com-
putational time of 10 simulations that train the model on
40-day historical data and then obtain the inference of 10-
day period. For real-time applications, the inference time is
important. Although GluNet consumes more time (878.11s)
than other models, all five models have good performance on
inference mode (less than one second). Compared with many
conventional CNN applications, GluNet has a light structure,
yet it still has much more parameters than other considered
models. In real-time implementation of such a system, we will
train the model on the cloud using GPUs and download the
trained model into mobile devices to execute prediction tasks.
In this case, it only takes 6 ms on an Android system to obtain
a single prediction for next 30 minutes, and 13.26s on Google
Cloud GPU to train the same amount of data.
V. CONCLUSION AND FUTURE WORK
In this paper, a glucose forecasting approach called GluNet
was proposed using deep neural networks. GluNet achieved
better glucose forecasting results in terms of accuracy (RMSE
and MARD) and in particular time lag. The proposed approach
provides an personalized predictive model by using individual
data, and algorithm’s computation cost is light enough to be
implemented on a mobile phone in real time. GluNet was
tested intensively on in silico virtual adult, virtual adolescent
and clinical adult datasets with leading performance.
In the future, we consider how to incorporate physiological
knowledge in our model. Currently we use them as optional
inputs to further improve the its performance.. A better ap-
proach is in investigation. We also plan to evaluate GluNet
with longer prediction horizons and apply it for over-night
hypoglycemia prediction.
VI. APPENDIX
A. Postprocessing
If W denotes the learnable convolution filter,
y = tanh(Wf,k ? x) σ(Wg,k ? x), (7)
where z is the output of unit, ?, are the convolution operator
and element-wise multiplication operator, respectively. tanh
denotes the tangent function and σ denotes the sigmoid
function. f, g, k denote filter, gate and layer index. We use the
residual in [39] and skip connections throughout the work.
B. Explanation of Time Lag
Fig. 12: Graphical representation of the ‘prediction time lag’.
Consider Alg. 1, Alg. 2 and Alg. 3 (Alg. 3 is to output the
current CGM measurements as the prediction result), and the
PH is set to 30 minutes. Then, the time lags of Alg. 1,2,3 are
approximately t1, t2 and t3, respectively, and t3 = 30 minutes.
We use Equation (6) to compute the ‘prediction time lag’
[31], [40]. This definition is different from the ‘CGM time
lag’ that denotes the time lag between the blood glucose and
CGM measurements. Fig. 12 shows a diagram of the time
lag. In practice it is not easy to obtain the time lag directly,
hence the cross correlation is used to compute it. From the
example one can see that a shorter time lag generally implies
a better prediction, because the algorithm with a shorter time
lag captures the curve changes quicker than other algorithms.
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